Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Synthesis and biological evaluation of dinucleoside methylphosphonates of 3′-azido-3′-deoxythymidine and 2′, 3′-dideoxycytidine — Frédéric Puech (1990) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Synthesis and biological evaluation of dinucleoside methylphosphonates of 3′-azido-3′-deoxythymidine and 2′, 3′-dideoxycytidine
Shared by
De Clercq Erik
KU Leuven
Synthesis and biological evaluation of dinucleoside methylphosphonates of 3′-azido-3′-deoxythymidine and 2′, 3′-dideoxycytidine
Article
1990
en
Authors
+4 more
FP
Frédéric Puech
GG
Gilles Gosselin
JB
Jan Balzarini
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
1990
Potent and Selective Anti‐HIV Activity of 5‐Chloro‐Substituted Derivatives of 3′‐Azido‐2′,3′‐Dideoxycytidine, 3′‐Fluoro‐2′,3′‐Dideoxycytidine, and 2′,3′‐Didehydro‐2′,3′‐Dideoxycytidine
Jan Balzarini
,
Arthur Van Aerschot
,
Piet Herdewijn
,
De Clercq Erik
Article
1996
Synthesis and Antiretroviral Evaluation of New Alkoxy and Aryloxy Phosphate Derivatives of 3‘-Azido-3‘-deoxythymidine
Andrew Tsotinis
,
Theodora Calogeropoulou
,
Maria Koufaki
,
Charikleia Souli
,
Jan Balzarini
,
De Clercq Erik
,
Alexandros Makriyannis
Article
1991
Synthesis and antiretrovirus properties of 5'-isocyano-5'-deoxythymidine,5'-isocyano-2',5'-dideoxyuridine,3'-azido-5'-isocyano-3',5'-dideoxythymidine, and 3'-azido-5'-isocyano-2',3',5'-trideoxyuridine
Josef Hiebl
,
Erich Zbiral
,
Jan Balzarini
,
De Clercq Erik
Article
1995
Homo Dinucleoside-α-hydroxyphosphonate Diesters as Prodrugs of the Antiviral Nucleoside Analogues 2',3'-Dideoxythymidine and 3'-Azido-2',3'-dideoxythymidine
Chris Meier
,
Lothar W. Habel
,
Wolfgang H.G. Laux
,
De Clercq Erik
,
Jan Balzarini
Article
1993
Synthesis of 2′‐Azido‐2′,3′‐didehydro‐2′,3′‐dideoxythymidine
Igor A. Mikhailopulo
,
Г. В. Зайцева
,
Elena V. Vaaks
,
Jan Balzarini
,
De Clercq Erik
,
Helmut Rosemeyer
,
Frank Seela
Discussion(0)
No comments yet. Be the first to comment.